David Stroncek
- Oncology top 10%
- Molecular Biology
- Genetics
- Immunology
- Clinical Biochemistry top 5%
- Co-authors
- Cindy DelbrookDaniel W. LeeBonnie YatesTerry J. FryNirali N. ShahMaryalice Stetler‐StevensonLing ZhangConstance M. Yuan
- Topics
- CAR-T cell therapy research (10 papers)Acute Lymphoblastic Leukemia research (5 papers)Cytomegalovirus and herpesvirus research (3 papers)
- Partner nations
- United StatesMalaysiaUnited Kingdom
In The Last Decade
David Stroncek
18 papers receiving 450 citations
Peers
Comparison fields: 5 of 58
- Oncology 233
- Molecular Biology 151
- Genetics 113
- Immunology 109
- Clinical Biochemistry 77
Countries citing papers authored by David Stroncek
This map shows the geographic impact of David Stroncek's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Stroncek with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Stroncek more than expected).
Fields of papers citing papers by David Stroncek
This network shows the impact of papers produced by David Stroncek. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Stroncek. The network helps show where David Stroncek may publish in the future.
Co-authorship network of co-authors of David Stroncek
This figure shows the co-authorship network connecting the top 25 collaborators of David Stroncek. A scholar is included among the top collaborators of David Stroncek based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Stroncek. David Stroncek is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 2 | |
| 3 | 4 | |
| 4 | 2 | |
| 5 | 90 | |
| 6 | 39 | |
| 7 | 27 | |
| 8 | 8 | |
| 9 | 40 | |
| 10 | 22 | |
| 11 | 15 | |
| 12 | 63 | |
| 13 | 1 | |
| 14 | 1 | |
| 15 | 3 | |
| 16 | 102 | |
| 17 | 32 | |
| 18 | 3 |
About David Stroncek
David Stroncek is a scholar working on Oncology, Hematology and Immunology, having authored 18 papers that have together received 455 indexed citations. Recurring topics across this work include CAR-T cell therapy research (10 papers), Acute Lymphoblastic Leukemia research (5 papers) and Cytomegalovirus and herpesvirus research (3 papers). The work is most often cited by research in Clinical Biochemistry (77 citations), Oncology (233 citations) and Immunology (109 citations). David Stroncek has collaborated with scholars based in United States, Malaysia and United Kingdom. Frequent co-authors include Cindy Delbrook, Daniel W. Lee, Bonnie Yates, Terry J. Fry, Nirali N. Shah, Maryalice Stetler‐Stevenson, Ling Zhang, Constance M. Yuan, Duck Jin Hong and Sang‐Guk Lee. Their work appears in journals such as Journal of Clinical Oncology, Blood and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.